Elixir Medical commences patient enrollment in Excella BD clinical trial
The Elixir DESyne BD stent combines a low drug dose (5µg/mm stent length) of internally developed macrocyclic lactone Novolimus, a metabolite of sirolimus and a low polymer load
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.